Growth Metrics

Core Laboratories (CLB) Cash & Current Investments (2022 - 2026)

Core Laboratories filings provide 5 years of Cash & Current Investments readings, the most recent being $22.8 million for Q1 2026.

  • On a quarterly basis, Cash & Current Investments rose 3.22% to $22.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $22.8 million, a 3.22% increase, with the full-year FY2025 number at $22.7 million, up 18.5% from a year prior.
  • Cash & Current Investments hit $22.8 million in Q1 2026 for Core Laboratories, up from $22.7 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $31.2 million in Q2 2025 to a low of $14.9 million in Q1 2024.
  • Median Cash & Current Investments over the past 5 years was $21.5 million (2024), compared with a mean of $20.9 million.
  • Biggest five-year swings in Cash & Current Investments: crashed 32.47% in 2024 and later soared 76.25% in 2025.
  • Core Laboratories' Cash & Current Investments stood at $15.4 million in 2022, then fell by 2.0% to $15.1 million in 2023, then increased by 26.7% to $19.2 million in 2024, then grew by 18.5% to $22.7 million in 2025, then increased by 0.52% to $22.8 million in 2026.
  • The last three reported values for Cash & Current Investments were $22.8 million (Q1 2026), $22.7 million (Q4 2025), and $25.6 million (Q3 2025) per Business Quant data.